Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.
Cohen JA, Cutter GR, Fischer JS, Goodman AD, Heidenreich FR, Kooijmans MF, Sandrock AW, Rudick RA, Simon JH, Simonian NA, Tsao EC, Whitaker JN; IMPACT Investigators.
Cohen JA, et al. Among authors: whitaker jn.
Neurology. 2002 Sep 10;59(5):679-87. doi: 10.1212/wnl.59.5.679.
Neurology. 2002.
PMID: 12221157
Clinical Trial.